Your browser doesn't support javascript.
loading
Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study.
Kahn, René S; Winter van Rossum, Inge; Leucht, Stefan; McGuire, Philip; Lewis, Shon W; Leboyer, Marion; Arango, Celso; Dazzan, Paola; Drake, Richard; Heres, Stephan; Díaz-Caneja, Covadonga M; Rujescu, Dan; Weiser, Mark; Galderisi, Silvana; Glenthøj, Birte; Eijkemans, Marinus J C; Fleischhacker, W Wolfgang; Kapur, Shitij; Sommer, Iris E.
Afiliación
  • Kahn RS; Department of Psychiatry, Brain Center Rudolf Magnus, Utrecht, Netherlands; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: rene.kahn@mssm.edu.
  • Winter van Rossum I; Department of Psychiatry, Brain Center Rudolf Magnus, Utrecht, Netherlands.
  • Leucht S; Department of Psychiatry and Psychotherapy, Technical University Munich, Munich, Germany.
  • McGuire P; Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; National Institute for Health Research Biomedical Research Centre at South London and Maudsley NHS Foundation Trust, London, UK.
  • Lewis SW; Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK; Greater Manchester Mental Health Foundation Trust, Manchester, UK.
  • Leboyer M; Institut National de la Santé et de la Recherche Médicale U 955, Psychiatrie Génétique et Psychopathologie, Créteil University Paris Est Créteil, Paris, France.
  • Arango C; Servicio de Psiquiatría del Niño y del Adolescente, Hospital General Universitario Gregorio Marañon, Universidad Complutense Madrid, Spain; Centro de Investigación Biomédica en Red de Salud Mental, Madrid, Spain.
  • Dazzan P; Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Drake R; Division of Psychology and Mental Health, School of Health Sciences, University of Manchester, Manchester, UK.
  • Heres S; Department of Psychiatry and Psychotherapy, Technical University Munich, Munich, Germany.
  • Díaz-Caneja CM; Servicio de Psiquiatría del Niño y del Adolescente, Hospital General Universitario Gregorio Marañon, Universidad Complutense Madrid, Spain; Centro de Investigación Biomédica en Red de Salud Mental, Madrid, Spain.
  • Rujescu D; Department of Psychiatry, University Hospital Halle, Halle, Germany.
  • Weiser M; Department of Psychiatry, Sheba Medical Center, Tel Aviv, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Galderisi S; Department of Psychiatry, Campania University Luigi Vanvitelli, Naples, Italy.
  • Glenthøj B; Center for Neuropsychiatric Schizophrenia Research, Mental Health Center Glostrup, Mental Health Services, Capital Region of Denmark, Glostrup, Denmark.
  • Eijkemans MJC; Department of Biostatistics and Research Support, University Medical Center Utrecht, Utrecht, Netherlands.
  • Fleischhacker WW; Medical University of Innsbruck, Department of Psychiatry and Psychosomatics, Division of Psychiatry, Innsbruck, Austria.
  • Kapur S; Institute of Psychiatry, Psychology and Neuroscience, King's Health Partners, London, UK.
  • Sommer IE; Department of Psychiatry, Brain Center Rudolf Magnus, Utrecht, Netherlands; Department of Neuroscience, University Medical Center, Groningen, Netherlands.
Lancet Psychiatry ; 5(10): 797-807, 2018 10.
Article en En | MEDLINE | ID: mdl-30115598
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esquizofrenia / Antipsicóticos / Clozapina / Olanzapina / Amisulprida Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Adolescent / Adult / Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Lancet Psychiatry Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esquizofrenia / Antipsicóticos / Clozapina / Olanzapina / Amisulprida Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Adolescent / Adult / Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Lancet Psychiatry Año: 2018 Tipo del documento: Article